Author:
Scribner R K,Marks M I,Finkhouse B D
Abstract
The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric infections by standard agar dilution methodology. The effect of inoculum size on activity was also assessed. BMY-28100 was more active than cephalexin or cefaclor against all bacterial species tested.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference4 articles.
1. In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum;Conrad D. A.;Antimicrob. Agents Chemother.,1985
2. Lennette E. H. A. Balows W. J. Hausler Jr. and H. J. Shadomy (ed.). 1985. Manual of clinical microbiology 4th ed. p. 143-153 154-175 and 387-393. American Society for Microbiology Washington D.C.
3. National Committee for Clinical Laboratory Standards. 1985. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A vol. 5 p. 583-587. National Committee for Clinical Laboratory Standards Villanova Pa.
4. Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin, and cephalothin for 118 strains of Haemophilus influenzae including "tolerant;Simard P.;micro-organisms. J. Antimicrob. Chemother.,1982
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献